Additional Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    Johns Hopkins (Site #: 71119)
    Baltimore MD. 21287
    View Details
  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    Duke University (Site #: 71139)
    Durham NC. 27710
    View Details
  • Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

    MD Anderson Cancer Center
    Houston TX. 77030
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Montréal QC. H2X 0A9
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Edmonton AB. T6G 2C8
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Sherbrooke QC. J1H 5N4
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Vancouver BC. V6Z 2K5
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of California San Francisco
    San Francisco CA. 94143
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of Michigan
    Ann Arbor MI. 48109
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of Kansas
    Kansas City KS. 66103
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of Colorado Denver
    Aurora CO. 80045
    View Details
  • DeciPHer-ILD: a Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    University of Kansas Medical Center
    Kansas City KS. 66160
    View Details
  • DeciPHer-ILD: a Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    University of New Mexico Health Sciences Center
    Albuquerque NM. 87131
    View Details
  • DeciPHer-ILD: a Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    University Medical Center - New Orleans
    New Orleans LA. 70112
    View Details
  • DeciPHer-ILD: a Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    Northwell Health
    New Hyde Park NY. 11042
    View Details
  • DeciPHer-ILD: a Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    Summit Health
    Bend OR. 97701
    View Details
  • DeciPHer-ILD: a Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    Legacy Research Institute
    Portland OR. 97210
    View Details
  • DeciPHer-ILD: a Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    AnMed Health
    Anderson SC. 29621
    View Details
  • DeciPHer-ILD: a Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

    Pulmonary Associates of Richmond, Inc.
    Richmond VA. 23230
    View Details
  • A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

    Northern Westchester Hospital
    Mount Kisco NY. 10549
    View Details